Development of Streptococcus mutans biofilm in the presence of human colostrum and 3'-sialyllactose

J Matern Fetal Neonatal Med. 2022 Feb;35(4):630-635. doi: 10.1080/14767058.2020.1730321. Epub 2020 Mar 12.

Abstract

Aim: To evaluate the initial adhesion and formation of Streptococcus mutans biofilm in vitro in the presence of saliva, human colostrum and 3'-sialyllactose.

Methods: Human colostrum and salivas were collected from 30 mothers and newborn postpartum. Eighteen hours culture of S. mutans was treated with colostrum or 3'-sialyllactose in three different moments: before, during, and after 24 h from the microbial inoculation. Salivas were also tested in conjunction with colostrum. The assays were realized in sterile 96-well flat-bottom microtiter plates for 24 h. The biofilms were fixed, washed, stained with crystal violet, and extracted. Absorbance was measured to evaluate biofilm growth mass.

Results: Colostrum applied after and during the inoculation decreased biofilm formation when compared with the control (p < .05). The presence of saliva increased the biofilm biomass (p < .05). The application of 3'-sialyllactose reduced biofilm formation independently of moments of application (p < .05).

Conclusion: Saliva contributed to the proliferation of biofilm and colostrum did not prevent the initial adhesion, but interfered in the accumulation and development of microorganisms in biofilms. 3'-sialyllactose significantly decreased biofilm formation. This information expands the importance of colostrum as a potent oral antimicrobial biofluid.

Keywords: Colostrum; Streptococcus mutans; breast feeding; sialyllactose.

MeSH terms

  • Biofilms
  • Colostrum*
  • Female
  • Humans
  • Infant, Newborn
  • Oligosaccharides
  • Pregnancy
  • Saliva
  • Streptococcus mutans*

Substances

  • 3'-sialyllactose
  • Oligosaccharides